Retrospective Cohort Study
Copyright ©The Author(s) 2020.
World J Hepatol. Oct 27, 2020; 12(10): 807-815
Published online Oct 27, 2020. doi: 10.4254/wjh.v12.i10.807
Table 2 Associations between sarcopenia status and outcomes
Outcome
n
Sarcopenia Median (IQR) or n (%)]
No Sarcopenia Median (IQR) or n (%)]
P value
Post-op survival for 90 d5523 (88)26 (90)1.000
Post-op survival for 1 yr5219 (76)22 (81)0.740
Post-op survival for 5 yr4113 (59)13 (68)0.746
ICU length of stay (d)553 (2, 4)2 (2, 5)0.696
Readmission to ICU544 (15)4 (14)1.000
Total length of stay (d)5513.5 (10, 27)21 (9, 28)0.661
Intubation days551.5 (1, 3)1 (1, 3)0.484
Pulmonary complications5410 (38)5 (18)0.131
Need for dialysis546 (23)7 (25)1.000
Readmission within 30 d5513 (50)13 (45)0.790
PNF552 (8)0 (0)0.219
Acute rejection552 (8)4 (14)0.672
Arterial complications556 (23)5 (17)0.739
Biliary complications558 (31)10 (34)1.000